Tell me something good, Kyverna…
…
TRENDING
5.3 USD
7.89 USD
0.18 USD
1.21 USD
0.0197 USD
0.04 USD
0.37 USD
15.52 USD
1.92 USD
5.81 USD
0.0247 USD
34.76 USD
1.74 USD
24.54 USD
0.12 USD
23.8 USD
0.038 USD
12.15 USD
38.25 USD
0.24 USD
Tell me something good, Kyverna Therapeutics announce positive SPS trial data Kyverna Therapeutics (NASDAQ: KYTX) stock surged 14% Monday after the company announced positive topline data from its registrational Phase 2 trial of mivocabtagene autoleucel (miv-cel) in stiff person syndrome (SPS). The clinical-stage biopharmaceutical company reported that miv-cel achieved statistically significant clinical benefits across all primary and secondary endpoints in …
Cencora to acquire majority stake in OneOncology for $3.6 billion Cencora Inc. (COR) announced it entered a definitive agreement to acquire the majority of outstanding equity interests it does not currently own in OneOncology from TPG for approximately $3.6 billion. The transaction values OneOncology at $7.4 billion enterprise value with an equity value of approximately $6 billion. Cencora will also …